4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000132
Director sold 1,419 shares at $22.60 ($32,069)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2023-08-21 | Sale | −1,419 | $22.60 | $32,069 | 145,799 | D |
| Open-market sales · 1,419 sh · avg $22.60 · $32,069 | |||||||
Loading xslF345X05/wk-form4_1692822662.xml…